Today: 9 April 2026
Rigetti stock price today: RGTI dips in year-end session as tech pullback pressures quantum names
31 December 2025
1 min read

Rigetti stock price today: RGTI dips in year-end session as tech pullback pressures quantum names

NEW YORK, December 31, 2025, 15:21 ET — Regular session.

  • Rigetti Computing shares down about 1.7% in afternoon trade, holding near $22
  • Quantum peers mixed as year-end trading stays thin and risk appetite wobbles
  • Focus shifts to early-2026 updates on orders, cash burn and the next earnings report

Rigetti Computing Inc (RGTI) shares were down 1.7% at $22.03 by 3:21 p.m. ET on Wednesday, 38 cents below their prior close. The stock traded between $21.96 and $22.65, with about 16.9 million shares changing hands.

The move came as Wall Street’s major indexes edged lower in thin year-end trading, keeping pressure on smaller, high-volatility names. “it’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters

That matters for Rigetti because late-year liquidity can dry up fast, amplifying intraday swings. Traders also tend to keep positions tight into holiday closures, making sentiment-driven sectors more prone to sharp moves.

Other quantum computing stocks moved in the same direction: IonQ fell about 0.9%, while Quantum Computing Inc slid about 0.7%. D-Wave Quantum was up about 0.4%.

Quantum computers use quantum bits, or qubits — the quantum version of bits in conventional machines — to process information in ways that can differ from standard computing. Commercial adoption is still early, so investors often trade the group on engineering milestones and risk appetite.

Rigetti last reported results on Nov. 10, when it posted third-quarter revenue of $1.9 million and an operating loss of $20.5 million. The company said cash and investments totaled $558.9 million as of Sept. 30, and it outlined targets for 150-plus qubits around end-2026 and 1,000-plus qubits around end-2027. It also pointed to about $5.7 million in purchase orders announced in September for two 9-qubit Novera systems, with delivery expected in the first half of 2026. Nasdaq

Investors are watching whether Rigetti can turn those targets into repeatable system sales and rising cloud usage, without a sharp acceleration in cash burn. They are also looking for more color on delivery timing and the mix of government, academic and early commercial customers.

The next obvious catalyst is the company’s fourth-quarter results and outlook. Rigetti has not announced a reporting date, but Zacks expects the next earnings release on March 4, 2026. Zacks

In the near term, traders are watching whether the stock can reclaim Tuesday’s close near $22.41 or revisits the session low around $21.96. The day’s range has been narrow, but that can change quickly when volume is light.

For the sector more broadly, the tug-of-war remains between long-term optimism about quantum computing and near-term questions around customer adoption and revenue durability. That dynamic has kept pure-play names prone to abrupt reversals.

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:10 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Chevron stock barely budges as oil ends 2025 under pressure; OPEC+ in focus
Previous Story

Chevron stock barely budges as oil ends 2025 under pressure; OPEC+ in focus

IBM stock slides nearly 2% in year-end session as profit-taking dents Dow
Next Story

IBM stock slides nearly 2% in year-end session as profit-taking dents Dow

Go toTop